Article Data

  • Views 538
  • Dowloads 116

Original Research

Open Access

ERECTILE DYSFUNCTION, HORMONE LEVELS, INFLAMMATION IN MALE PATIENTS WITH METABOLIC SYNDROME

  • Jian-Kang Chao1,2
  • Mi-Chia Ma3
  • I-Hsin Candy Chao4

1Department of Psychiatry, Yuli branch, Taipei Veterans General Hospital, Hualien, Taiwan

2Department of social work, National Pingtung University of Science and Technology, Pingtung, Taiwan

3Department of Statistics, National Cheng Kung University, Tainan, Taiwan

4Faculty of Business, University of Technology Sydney, Sydney, Australia

DOI: 10.22374/1875-6859.14.4.2 Vol.14,Issue 4,September 2018 pp.25-37

Published: 24 September 2018

*Corresponding Author(s): Jian-Kang Chao E-mail: jiankangchao2000@yahoo.com.tw

PDF (3.87 MB)

Abstract

Background and Objective

The overall prevalence of metabolic syndrome (MetS) and obesity in male Taiwanese is very high, but the impacts on MetS, sexuality and sex hormones, inflammation markers in male erectile dysfunction (ED) are not entirely clear in relevance. This study’s aim is to investigate males with MetS and its components, sex hormones, inflammatory risk factors, sexuality and ED correlation.

Material and Methods

This was a cross-sectional study of 89 male participants, and data collected included demographic data, biochemistry, sex hormones, inflammatory risk factors and International Index of Erectile Function (IIEF-15) questionnaire. Descriptive analysis, difference analysis, and logistic regression model were used to identify relevant variables that may affect ED.

Result

Among our 89 subjects, 46 had MetS (51.7%) and 31 subjects with MetS had ED (67.4%). The presence of MetS had a significant correlation with lower IIEF-ED scores, lower intercourse satisfaction scores, lower total testosterone (TT) serum level (p<0.01) and also presence of MetS had a significant correlation with higher D-dimer, fibrinogen and  C-reactive protein (CRP) serum level. The results also showed that the greater the number of MetS components had the higher the prevalence of ED and the higher the abnormal CRP, fibrinogen and D-dimer (p<0.05). After adjusting for age, we used sexual desire dysfunction, Met S and TT abnormal to run the logistic regression model for predictors of ED, and the analysis showed that there was a significant difference for sexual desire dysfunction (OR = 8.845, 95% CI=2.203 – 35.516, P = 0.002), Met S (OR = 4.100, 95% CI = 1.343 – 12.520, P = 0.013) and TT abnormal (OR = 3.287, 95% CI = 1.022 – 10.570, P = 0.046).

Conclusion

To prevent the development of ED, we should encourage a change in lifestyle to prevent the development of MetS, and early identification and treatment of MetS risk factors might be helpful to prevent ED and secondary cardiovascular disease, including diet and lifestyle interventions.


Keywords

erectile dysfunction; metabolic syndrome; International Index of Erectile Function; testos-terone; inflammatory risk factors

Cite and Share

Jian-Kang Chao,Mi-Chia Ma,I-Hsin Candy Chao. ERECTILE DYSFUNCTION, HORMONE LEVELS, INFLAMMATION IN MALE PATIENTS WITH METABOLIC SYNDROME. Journal of Men's Health. 2018. 14(4);25-37.

References

1. Lewis R, Hatzichristou D, Laumann E, et al. Epidemi-ology and natural history of erectile dysfunction: Risk factors including iatrogenic and aging. In: Jardin A, Wagner G, Khoury S, Giuliano F, Padma-Nathan H, Rosen R, eds. Erectile dysfunction. Plymouth: Health Publications Ltd; 2000.

2. Strong TD, Gebska MA, Champion HC, et al. Stem and endothelial progenitor cells in erection biology. Int J Impot Res 2008;20:243–54.

3. Quek KF, Sallam AA, Ng CH, et al. Prevalence of sexual problems and its association with social, psychological and physical factors among men in a Malaysian popula-tion: A cross-sectional study. J Sex Med 2008;5:70–6.

4. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts male aging study. J Urol-ogy 1994;151:54–61.

5. Vlachopoulos C, Rokkas K, Ioakeimidis N, et al. Inflammation, metabolic syndrome, erectile dysfunc-tion, and coronary artery disease: common links. Eur Urol 2007;52:1590–600.

6. Kaiser DR, Billups K, Mason C, et al. Impaired bra-chial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004;43:179–84.

7. Balon R, Segraves RT. Clinical manual of sexual disorder: Male erectile disorder. Am Psychiatr Publ 2009:213–49.

8. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537–44.

9. Tikkanen MJ, Jackson G, Tammela T, et al. Erectile dysfunction as a risk factor for coronary heart disease: Implications for prevention. Int J Clin Pract 2007;61:265–8.

10. Goldstein I. The mutually reinforcing triad of depres-sive symptoms, cardiovascular disease, and erectile dysfunction. Am J Cardiol 2000;86:41F–45F.

11. Chew KK, Bremner A, Jamrozik K, et al. Male erectile dysfunction and cardiovascular disease: Is there an intimate nexus? J Sex Med 2008;5:928–34.

12. Shabsigh R, Shah M, Sand M. Erectile dysfunction and men’s health: Developing a comorbidity risk calculator. J Sex Med 2008;5:1237–43.

13. Ebron K, Andersen CJ, Aguilar D, et al. A larger body mass index is associated with increased atherogenic dyslipidemia, insulin resistance, and low-grade inflam-mation in individuals with metabolic syndrome. Metab Syndr Relat Disord 2015;13(10):458–564. doi: 10.1089/met.2015.0053.

14. Slagter SN, van Vliet-Ostaptchouk JV, van Beek AP, et al. Health-related quality of life in relation to obesity grade, type 2 diabetes, metabolic syndrome and inflam-mation. PLoS One 2015;10(10):e0140599. [PubMed: 26474291]

15. Marques-Rocha JL, Milagro FI, Mansego ML, et al. Expression of inflammation-related miRNAs in white blood cells from subjects with metabolic syndrome after 8 weeks of following a Mediterranean diet-based weight loss program. Nutrition 2016;32:48–55. doi: 10.1016/j.nut.2015.06.008

16. Lin YC, Hsu LA, Ko YS, et al. Impact of conventional cardiovascular risk factors on acute myocardial in-farction in young adult Taiwanese. Acta Cardiol Sin 2010;26:228–34.

17. Su CH, Fang CY, Chen JS, et al. Prevalence of meta-bolic syndrome and its relationship with cardiovascular disease among hypertensive patients 55-80 years of age. Acta Cardiol Sin 2011;27:229–37.

18. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010;56:1113–2.

19. Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc 2006;105(8):626–35.

20. Yao CA, Lee LT, Chen CY, et al. The study of metabolic syndrome in elderly receiving health check-up. Taiwan J Geriatr Gerontol 2005;1:18–25.

21. Hung TC, Chen CY, Cheng SJ, et al. Comparison of the prevalence of metabolic syndrome between the criteria for Taiwanese and Japanese and the projected probability of stroke in elderly hypertensive Taiwanese. Int J Gerontol 2009;3:233–40.

22. Lin YH, Chang HT, Tseng YH, et al. Characteristics and health behavior of newly developed metabolic syndrome among community-dwelling elderly in Taiwan. Int J Gerontol 2013;7:90–6.

23. Boyko EJ, de Courten M, Zimmet PZ, et al. Features of the metabolic syndrome predict higher risk for dia-betes and impaired glucose tolerance. Diabetes Care 2000;23:1242–8.

24. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486–897.

25. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005;28:2745–9.

26. Zimmet P, Alberti KGMM, Shaw J. Global and so-cietal implications of the diabetes epidemic. Nature 2001;414:782–7.

27. Tsou MT, Chang BCC, Huang WH, et al. Prevalence of metabolic syndrome and risk factor analysis among urban elderly in one medical center in Northern Taiwan. Int J Gerontol 2014;8:127–32.

28. Raheem OA, Su JJ, Wilson JR, et al. The Association of Erectile Dysfunction and Cardiovascular Disease: a systematic critical review. Am J Mens Health 2017;11(3):552–63. [Epub ahead of print].

29. Fung MM, Bettencourt R, Barrett-Connor E. Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study. J Am Coll Cardiol 2004;43:1405–11.

30. Feldman HA, Johannes CB, Derby CA, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000;30:328–38.

31. Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822–30. [PubMed: 9187685]

32. Chandel A, Dhindsa S, Topiwala S, et al. Testosterone concentration in young patients with diabetes. Diabetes Care 2008;31:2013–7.

33. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666–72.

34. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel  on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285:2486–97.

35. Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004;27:1182–6.

36. Heidler S, Temml C, Broessner C, et al. Is the meta-bolic syndrome an independent risk factor for erectile dysfunction? J Urol 2007;177:651–4.

37. Demir T, Demir O, Kefi A, et al. Prevalence of erectile dysfunction in patients with metabolic syndrome. Int J Urol 2006;13:385–8. [PubMed]

38. Sanjay S, Bharti GS, Manish G, et al. Metabloic syndrome: An independence risk factor for erectile dysfunction. Indian J Endocrinol Metab 2015; 19(2):277–82. doi:10.4103/2230-8210.149322

39. Suleiman-Martos Y, Arrabal-Polo M, Jimenez-Pacheco A, et al. Metabolic syndrome, hormone levels and inflammation in patients with erectile dysfunction. Endocrine Abstracts 2012;29:321

40. Aslan Y, Sezgin T, Tuncel A, et al. Is type 2 diabetes mellitus a cause of severe erectile dysfunction in patients with metabolic syndrome? Urology 2009;74:561–4.

41. Heidler S, Temml C, Broessner C, et al. Is the meta-bolic syndrome an independent risk factor for erectile dysfunction? J Urol 2007;177:651–4.

42. Yeh HC, Wang CJ, Lee YC, et al. Association among metabolic syndrome, testosterone level and severity of erectile dysfunction. Kaohsiung J Med Sci 2008;24:240–7.

43. Borges R, Temido P, Sousa L, et al. Metabolic syndrome and sexual (dys)function. J Sex Med 2009;6:2958–75.

44. García-Cruz E, Leibar-Tamayo A, Romero J, et al. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction. J Sex Med 2013; 10:2529–38.

45. Folsom AR, Gottesman RF, Appiah D, et al. Plasma

D- Dimer and Incident Ischemic Stroke and Coronary Heart Disease: the Atherosclerosis Risk in Communi-ties Study. Stroke 2016;47(1):18–23. doi:10.1161/STROKEAHA.115.011035

46. Martinez M, Cuker A, Mills A, et al. Nitrated fibrinogen is a biomarker of oxidative stress in venous thrombo-embolism. Free Radic Biol Med 2012;53(2): 230–6. doi:10.1016/j.freeradbiomed.2012.05.004.

47. Vlachopoulos C, Rokkas K, Ioakeimidis N, et al. Inflammation, metabolic syndrome, erectile dysfunc-tion, and coronary artery disease: common links. Eur Urol 2007;52:1590–600.

48. Al-Hunayan A, Al-Mutar M, Kehinde EO, Thalib L, Al-Ghorory M. The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus. BJU Int 2007;99:130–4.

49. Grover SA, Lowensteyn I, Kaouache M, et al. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Arch Intern Med 2006;166(2):213–9.

Abstracted / indexed in

Science Citation Index Expanded Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Social Sciences Citation Index Social Sciences Citation Index contains over 3,400 journals across 58 social sciences disciplines, as well as selected items from 3,500 of the world’s leading scientific and technical journals. More than 9.37 million records and 122 million cited references date back from 1900 to present.

Current Contents - Social & Behavioral Sciences Current Contents - Social & Behavioral Sciences provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in the social and behavioral sciences.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

SCOPUS Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

DOAJ DOAJ is a community-curated online directory that indexes and provides access to high quality, open access, peer-reviewed journals.

CrossRef Crossref makes research outputs easy to find, cite, link, assess, and reuse. Crossref committed to open scholarly infrastructure and collaboration, this is now announcing a very deliberate path.

Portico Portico is a community-supported preservation archive that safeguards access to e-journals, e-books, and digital collections. Our unique, trusted process ensures that the content we preserve will remain accessible and usable for researchers, scholars, and students in the future.

Submission Turnaround Time

Conferences

    Top